Skip to main content
Fig. 3 | Lipids in Health and Disease

Fig. 3

From: Low-density lipoprotein cholesterol goal attainment in patients with clinical evidence of familial hypercholesterolemia and elevated Lp(a)

Fig. 3

LDL-C target value attainment under current treatment. (A) probability of phenotypical FH by DLCN criteria (unlikely FH DLCN score < 3, possible FH DLCN score 3–5, probable FN DLCN score 6–8, definite FH DLCN score > 8). (B) Lp(a) ≥ 50 mg/dL (107 nmol/L). (C) prevalence of either probable or definite FH (DLCN criteria) and/or Lp(a) ≥ 50 mg/dL. Percentages of patients reaching (green) or failing (red) their individual LDL-C target based on ESC/EAS guidelines 2016 for risk groups (very high-risk LDL-C < 70 mg/dL, high risk LDL-C < 100 mg/dl, intermediate risk < 115 mg/dL)

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X